Results 131 to 140 of about 306 (179)

Superoxide dismutase and neurological disorders. [PDF]

IBRO Neurosci Rep
Chidambaram SB, Anand N, Varma SR, Ramamurthy S, Vichitra C, Sharma A, Mahalakshmi AM, Essa MM.   +7 more
europepmc   +1 more source

Protection Activity of 1,4-Naphthoquinones in Rotenone-Induced Models of Neurotoxicity. [PDF]

Mar Drugs
Agafonova I, Chingizova E, Chaikina E, Menchinskaya E, Kozlovskiy S, Likhatskaya G, Sabutski Y, Polonik S, Aminin D, Pislyagin E.   +9 more
europepmc   +1 more source

Cytisin Amidophosphate : The New Cytoprotector

Cytisin Amidophosphate : The New Cytoprotector
openaire   +1 more source

Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death

European Journal of Medicinal Chemistry, 2017
Activation of nuclear factor erythroid-2-related factor 2 (Nrf2) has been proven to be an effective means to prevent the development of cancer, and natural curcumin stands out as a potent Nrf2 activator and cancer chemopreventive agent. In this study, we synthesized a series of curcumin analogs by introducing the geminal dimethyl substituents on the ...
Bo Zhou
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Natural Stilbene Polyphenols as Yarrowia lipolytica Cell Cytoprotectors at Heat Stress

Biotekhnologiya, 2021
Using the extremophilic yeast of Yarrowia lipolytica, a new model has been proposed to study the protective properties of stilbene polyphenols, namely resveratrol and pinosylvin, under heat shock. It was shown that a short-term thermal exposure of yeast cells (55 C, 25 min) led to a 40% decrease in the colony-forming ability of the population, a ...
N.N. Gessler, E.P. Isakova, Yu.I. Deryabina   +2 more
exaly   +2 more sources

Possibilities of using cytoprotectors in complex therapy of chronic coronary heart disease

Kardiologiya I Serdechno-Sosudistaya Khirurgiya
The chronic form of coronary heart disease (CHD) is one of the most common types of cardiovascular pathology in the Russian Federation. The main causes of myocardial ischemia are a decrease in coronary reserve, as well as a decrease in coronary blood flow due to atherosclerotic stenosis.
N Yu Borovkova
exaly   +2 more sources

ASTHENIC POST-COVID-19 SYNDROME: CLINICAL EFFICACY OF CYTOPROTECTORS

Vestnik SurGU. Meditsina
The study aims to assess the mechanism and efficacy of cytoprotectors as a supplementary therapy for asthenia based on a literature review. The study discusses the cardioprotective effect of exogenous phosphocreatine and meldonium efficacy, their possible role following the COVID-19 infection, especially in concomitant cardiac pathology, post-COVID-19 ...
exaly   +2 more sources

Cytoprotectors and Pharmacological Antagonists in Medical Toxicology

Proceedings
exaly   +2 more sources

Molecular mechanisms of the cytoprotector cramizol effect in the experimental dyslipidemia model

Biomeditsinskaya Khimiya, 2020
The tested drug cramizol exhibits lipid-lowering and anti-atherogenic effects. Cramizol reduces blood cholesterol and triglycerides. It also increases HDL and reduces the atherogenic index in rats with the chronic dyslipidemia model induced by a hypercholesterol diet.
A V, Lizunov, I V, Okunevich, A A, Lebedev, E R, Bychkov, L B, Piotrovskiy, P D, Shabanov   +5 more
openaire   +2 more sources